ELEVANCE HEALTH INC (A58.DE) Stock Earnings & Estimates
Europe - Frankfurt Stock Exchange - FRA:A58 - US0367521038 - Common Stock
320.9 EUR
+4.8 (+1.52%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 156.595B 12.95% | 171.34B 9.42% | 176.81B 3.19% | 200.184B 13.22% | 207.165B 3.49% | 216.644B 4.58% | 218.468B 0.84% | 221.918B 1.58% | N/A | N/A | N/A | |
| EBITDA YoY % growth | 10.165B -2.79% | 11.242B 10.60% | 10.549B -6.16% | 10.569B 0.19% | 9.855B -6.76% | 10.97B 11.31% | 14.064B 28.20% | 16.079B 14.33% | 18.178B 13.05% | 19.93B 9.64% | 21.31B 6.92% | |
| EBIT YoY % growth | 8.49B -7.26% | 9.497B 11.86% | 9.156B -3.59% | 9.698B 5.92% | 8.846B -8.79% | 9.589B 8.40% | 13.011B 35.69% | 12.57B -3.39% | N/A | N/A | N/A | |
| Operating Margin | 5.42% | 5.54% | 5.18% | 4.84% | 4.27% | 4.43% | 5.96% | 5.66% | N/A | N/A | N/A | |
| EPS YoY % growth | 29.05 11.86% | 33.11 13.98% | 32.97 -0.42% | 30.29 -8.14% | 27.31 -9.83% | 31.57 15.60% | 41.26 30.71% | 47.94 16.19% | 57.43 19.79% | 64.86 12.94% | 71.10 9.62% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.18 -17.11% | 10.42 -12.97% | 8.03 -9.11% | 5.55 -7.98% | 3.34 4.78% | 12.26 17.73% | 8.94 11.32% | 6.28 13.15% | 3.34 0.04% |
| Revenue Q2Q % growth | 50.315B 10.72% | 51.437B 5.48% | 51.945B 5.11% | 52.778B 5.37% | 51.93B 3.21% | 53.68B 4.36% | 54.726B 5.35% | 55.99B 6.09% | 54.851B 5.62% |
| EBITDA Q2Q % growth | 1.269B -45.75% | 3.675B 4.58% | 2.883B -14.86% | 2.056B -29.03% | 1.306B 2.92% | 4.086B 11.18% | 3.008B 4.34% | 2.147B 4.43% | 1.445B 10.64% |
| EBIT Q2Q % growth | 1.126B 19.03% | 3.452B 9.90% | 2.7B 2.54% | 1.863B 6.03% | 977.52M -13.19% | 3.665B 6.17% | 2.757B 2.11% | 1.94B 4.13% | 1.105B 13.04% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 6.03 -27.96% | 4.98 | 1.05 | 21.02% |
| Q2 2025 Q2Q % growth | 8.84 -12.65% | 9.04 | -0.20 | -2.26% |
| Q1 2025 Q2Q % growth | 11.97 12.50% | 11.50 | 0.47 | 4.12% |
| Q4 2024 Q2Q % growth | 3.84 -31.67% | 3.83 | 0.01 | 0.17% |
| Q3 2024 Q2Q % growth | 8.37 -6.90% | 9.76 | -1.39 | -14.20% |
| Q2 2024 Q2Q % growth | 10.12 11.95% | 10.11 | 0.01 | 0.10% |
| Q1 2024 Q2Q % growth | 10.64 12.47% | 10.64 | 0.00 | 0.03% |
| Q4 2023 Q2Q % growth | 5.62 7.46% | 5.70 | -0.08 | -1.40% |
| Q3 2023 Q2Q % growth | 8.99 19.39% | 8.52 | 0.47 | 5.47% |
| Q2 2023 Q2Q % growth | 9.04 12.44% | 8.88 | 0.16 | 1.75% |
| Q1 2023 Q2Q % growth | 9.46 14.67% | 9.35 | 0.11 | 1.13% |
| Q4 2022 Q2Q % growth | 5.23 1.75% | 5.24 | -0.01 | -0.20% |
| Q3 2022 Q2Q % growth | 7.53 10.90% | 7.22 | 0.31 | 4.30% |
| Q2 2022 Q2Q % growth | 8.04 14.37% | 7.82 | 0.22 | 2.84% |
| Q1 2022 Q2Q % growth | 8.25 17.69% | 7.89 | 0.36 | 4.54% |
| Q4 2021 Q2Q % growth | 5.14 102.36% | 5.16 | -0.02 | -0.46% |
| Q3 2021 Q2Q % growth | 6.79 61.67% | 6.43 | 0.36 | 5.53% |
| Q2 2021 Q2Q % growth | 7.03 -23.59% | 6.40 | 0.63 | 9.93% |
| Q1 2021 Q2Q % growth | 7.01 8.18% | 6.58 | 0.43 | 6.57% |
| Q4 2020 Q2Q % growth | 2.54 | 2.55 | -0.01 | -0.21% |
| Q3 2020 Q2Q % growth | 4.20 | 4.19 | 0.01 | 0.15% |
| Q2 2020 Q2Q % growth | 9.20 | 8.96 | 0.24 | 2.64% |
| Q1 2020 Q2Q % growth | 6.48 | 6.54 | -0.06 | -0.94% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 50.087B 10.95% | 49.863B | 224M | 0.45% |
| Q2 2025 Q2Q % growth | 49.421B 13.23% | 48.717B | 704M | 1.45% |
| Q1 2025 Q2Q % growth | 48.765B 14.53% | 46.753B | 2.012B | 4.30% |
| Q4 2024 Q2Q % growth | 45.442B 6.55% | 45.311B | 131M | 0.29% |
| Q3 2024 Q2Q % growth | 45.145B 5.36% | 43.8B | 1.345B | 3.07% |
| Q2 2024 Q2Q % growth | 43.646B -0.06% | 43.485B | 161M | 0.37% |
| Q1 2024 Q2Q % growth | 42.577B 0.96% | 43.052B | -475M | -1.10% |
| Q4 2023 Q2Q % growth | 42.647B 6.81% | 42.466B | 181M | 0.43% |
| Q3 2023 Q2Q % growth | 42.849B 7.29% | 43.042B | -193M | -0.45% |
| Q2 2023 Q2Q % growth | 43.672B 13.05% | 41.917B | 1.755B | 4.19% |
| Q1 2023 Q2Q % growth | 42.172B 10.70% | 41.24B | 932M | 2.26% |
| Q4 2022 Q2Q % growth | 39.929B 9.15% | 40.038B | -109M | -0.27% |
| Q3 2022 Q2Q % growth | 39.939B 11.49% | 39.479B | 460M | 1.17% |
| Q2 2022 Q2Q % growth | 38.632B 14.12% | 38.51B | 122M | 0.32% |
| Q1 2022 Q2Q % growth | 38.095B 17.63% | 37.727B | 368M | 0.98% |
| Q4 2021 Q2Q % growth | 36.581B 15.18% | 36.878B | -297M | -0.81% |
| Q3 2021 Q2Q % growth | 35.822B 14.90% | 35.652B | 170M | 0.48% |
| Q2 2021 Q2Q % growth | 33.851B 15.72% | 33.536B | 315M | 0.94% |
| Q1 2021 Q2Q % growth | 32.385B 9.12% | 33.272B | -887M | -2.67% |
| Q4 2020 Q2Q % growth | 31.76B | 31.089B | 671M | 2.16% |
| Q3 2020 Q2Q % growth | 31.176B | 30.111B | 1.065B | 3.54% |
| Q2 2020 Q2Q % growth | 29.253B | 29.542B | -289M | -0.98% |
| Q1 2020 Q2Q % growth | 29.678B | 28.885B | 793M | 2.75% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.44% | -23.7% | 0% | 0.31% |
| Revenue | -0.09% | 0.32% | 0.05% | 0.65% |